OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuronal apolipoprotein E4 increases cell death and phosphorylated tau release in alzheimer disease
Anil R. Wadhwani, Amira Affaneh, Stephanie Van Gulden, et al.
Annals of Neurology (2019) Vol. 85, Iss. 5, pp. 726-739
Open Access | Times Cited: 116

Showing 26-50 of 116 citing articles:

Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker–based case–control study
Hana Saddiki, Aurore Fayossé, Emmanuel Cognat, et al.
PLoS Medicine (2020) Vol. 17, Iss. 8, pp. e1003289-e1003289
Open Access | Times Cited: 55

The Antioxidant Activity of Limonene Counteracts Neurotoxicity Triggered byAβ1-42 Oligomers in Primary Cortical Neurons
Ilaria Piccialli, Valentina Tedeschi, Lucia Caputo, et al.
Antioxidants (2021) Vol. 10, Iss. 6, pp. 937-937
Open Access | Times Cited: 47

Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases
Della Grace Thomas Parambi, Khalid Saad Alharbi, Rajesh Kumar, et al.
Molecular Neurobiology (2021) Vol. 59, Iss. 1, pp. 191-233
Open Access | Times Cited: 43

Effect of metal ions on Alzheimer's disease
Fan Liu, Zhuo Zhang, Lin Zhang, et al.
Brain and Behavior (2022) Vol. 12, Iss. 3
Open Access | Times Cited: 31

From degenerative disease to malignant tumors: Insight to the function of ApoE
Ganggang Miao, Danping Zhuo, Xue Han, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114127-114127
Open Access | Times Cited: 31

Association of Apolipoprotein E ɛ4, Educational Level, and Sex With Tau Deposition and Tau-Mediated Metabolic Dysfunction in Older Adults
Vijay K. Ramanan, Anna Castillo, David S. Knopman, et al.
JAMA Network Open (2019) Vol. 2, Iss. 10, pp. e1913909-e1913909
Open Access | Times Cited: 52

HDL Proteome and Alzheimer’s Disease: Evidence of a Link
Judit Marsillach, Maria Pia Adorni, Francesca Zimetti, et al.
Antioxidants (2020) Vol. 9, Iss. 12, pp. 1224-1224
Open Access | Times Cited: 45

β-amyloid: The known unknowns
Scott Ayton, Ashley I. Bush
Ageing Research Reviews (2020) Vol. 65, pp. 101212-101212
Closed Access | Times Cited: 39

The power and the promise of CRISPR/Cas9 genome editing for clinical application with gene therapy
Ning Guo, Ji‐Bin Liu, Wen Li, et al.
Journal of Advanced Research (2021) Vol. 40, pp. 135-152
Open Access | Times Cited: 39

Application of CRISPR/Cas9 in Alzheimer’s Disease
Likui Lu, Yu Xi, Yongle Cai, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 38

CRISPR/Cas9 system and its applications in nervous system diseases
Haibin Jiang, Mengyan Tang, Zidi Xu, et al.
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 675-686
Open Access | Times Cited: 14

Bio–Nano Toolbox for Precision Alzheimer's Disease Gene Therapy
Yang Liu, Xue Xia, Meng Zheng, et al.
Advanced Materials (2024) Vol. 36, Iss. 29
Closed Access | Times Cited: 5

Deciphering the role of APOE in cerebral amyloid angiopathy: from genetic insights to therapeutic horizons
H. B. Hu, Suk-King Wan, Yongxian Hu, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access

Could Blood Transfusion Increase the Risk of Alzheimer’s Disease? A Narrative Review
Xiaoyue Li, Renjun Pei, Zhangcheng Fei, et al.
Healthcare (2025) Vol. 13, Iss. 5, pp. 452-452
Open Access

An overview in interactions and biosensors of multiple biomarkers of Alzheimer’s disease
Xuyuan Chen, Wei Yuan, Xiaobing Wang, et al.
Chemical Engineering Journal (2025), pp. 161121-161121
Closed Access

CRISPR/Cas9 novel therapeutic road for the treatment of neurodegenerative diseases
Ansar Karimian, Negar Gorjizadeh, Forough Alemi, et al.
Life Sciences (2020) Vol. 259, pp. 118165-118165
Closed Access | Times Cited: 37

In Vivo Chimeric Alzheimer’s Disease Modeling of Apolipoprotein E4 Toxicity in Human Neurons
Ramsey Najm, Kelly A. Zalocusky, Misha Zilberter, et al.
Cell Reports (2020) Vol. 32, Iss. 4, pp. 107962-107962
Open Access | Times Cited: 36

HDL-like-Mediated Cell Cholesterol Trafficking in the Central Nervous System and Alzheimer’s Disease Pathogenesis
Carla Borràs, Aina Mercer, Sònia Sirisi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9356-9356
Open Access | Times Cited: 21

Current understanding of the interactions between metal ions and Apolipoprotein E in Alzheimer’s disease
Yanhui Zhang, Huiling Gao, Wei Zheng, et al.
Neurobiology of Disease (2022) Vol. 172, pp. 105824-105824
Closed Access | Times Cited: 20

Insulin Resistance, a Risk Factor for Alzheimer’s Disease: Pathological Mechanisms and a New Proposal for a Preventive Therapeutic Approach
Flora Affuso, Filomena Micillo, Sergio Fazio
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1888-1888
Open Access | Times Cited: 4

Multi-functional role of apolipoprotein E in neurodegenerative diseases
Sadequl Islam, Arshad Ali Noorani, Yang Sun, et al.
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access

From Genetics to Neuroinflammation: The Impact of ApoE4 on Microglial Function in Alzheimer’s Disease
Daniela Dias, Camila C. Portugal, João B. Relvas, et al.
Cells (2025) Vol. 14, Iss. 4, pp. 243-243
Open Access

Scroll to top